SLGL
Sol-Gel Technologies Ltd.stockNASDAQ
sol-gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. our lead product candidates, vered for the treatment of papulopustular rosacea and twin and sirs-t for the treatment of acne vulgaris ("acne") are based upon our proprietary microencapsulation delivery system. this technology consists of microcapsules made of silica. based on our pre-clinical and clinical data, this delivery system should enable us to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs. our silica-based delivery system improves the tolerability of topical dermatological drug products by entrapping drug substances in porous silica microcapsules. this creates a protective barrier between the drug substance and the skin and controls the release rate of the drug substance. our delivery system also enables to produce novel fixed-dose combinations th
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 56.25 | 2026-11-12 | -3.80% | 0.157 |
| 1M | 64.98 | 2026-10-19 | -16.72% | 0.818 |
| 3M | 78.59 | 2026-08-19 | -31.14% | 0.873 |
| 6M | 63.31 | 2026-05-19 | -14.52% | 1.108 |
| 1Y | 36.04 | 2025-11-19 | +50.15% | 1.019 |
| 2Y | 4.31 | 2024-11-19 | +1155.57% | — |
| 5Y | 85.70 | 2021-11-19 | -36.85% | 0.504 |
Sol-Gel Technologies Ltd. (NASDAQ:SLGL) stock price today is $54.12, and today's volume is 23,723. SLGL is up 1.415% today. The 30 day average volume is 38,493. SLGL market cap is $177.17M with 3.27M shares outstanding.